Global Protein Drugs Market Insights and Forecast to 2028

Publisher Name :
Date: 28-Feb-2022
No. of pages: 108
Inquire Before Buying

Protein Drugs market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Protein Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

- Antibody Drugs

- Peptide Hormones

- Blood Products

- Enzymes

Segment by Application

- Hospitals

- Clinics

- Other

By Company

- Eli Lilly

- Abbott Laboratories

- UCB Group

- Schering-Plough Corporation

- Genentech

- Johnson&Johnson

- Bristol-Myers Squibb

- Novo Nordisk

- Biogen Idec

- Dendreon Corporation

- Amgen Inc.

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Global Protein Drugs Market Insights and Forecast to 2028

Table of Contents
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Protein Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Antibody Drugs
1.2.3 Peptide Hormones
1.2.4 Blood Products
1.2.5 Enzymes
1.3 Market by Application
1.3.1 Global Protein Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Protein Drugs Market Perspective (2017-2028)
2.2 Protein Drugs Growth Trends by Region
2.2.1 Protein Drugs Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Protein Drugs Historic Market Size by Region (2017-2022)
2.2.3 Protein Drugs Forecasted Market Size by Region (2023-2028)
2.3 Protein Drugs Market Dynamics
2.3.1 Protein Drugs Industry Trends
2.3.2 Protein Drugs Market Drivers
2.3.3 Protein Drugs Market Challenges
2.3.4 Protein Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Protein Drugs Players by Revenue
3.1.1 Global Top Protein Drugs Players by Revenue (2017-2022)
3.1.2 Global Protein Drugs Revenue Market Share by Players (2017-2022)
3.2 Global Protein Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Protein Drugs Revenue
3.4 Global Protein Drugs Market Concentration Ratio
3.4.1 Global Protein Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Protein Drugs Revenue in 2021
3.5 Protein Drugs Key Players Head office and Area Served
3.6 Key Players Protein Drugs Product Solution and Service
3.7 Date of Enter into Protein Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Protein Drugs Breakdown Data by Type
4.1 Global Protein Drugs Historic Market Size by Type (2017-2022)
4.2 Global Protein Drugs Forecasted Market Size by Type (2023-2028)
5 Protein Drugs Breakdown Data by Application
5.1 Global Protein Drugs Historic Market Size by Application (2017-2022)
5.2 Global Protein Drugs Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Protein Drugs Market Size (2017-2028)
6.2 North America Protein Drugs Market Size by Type
6.2.1 North America Protein Drugs Market Size by Type (2017-2022)
6.2.2 North America Protein Drugs Market Size by Type (2023-2028)
6.2.3 North America Protein Drugs Market Share by Type (2017-2028)
6.3 North America Protein Drugs Market Size by Application
6.3.1 North America Protein Drugs Market Size by Application (2017-2022)
6.3.2 North America Protein Drugs Market Size by Application (2023-2028)
6.3.3 North America Protein Drugs Market Share by Application (2017-2028)
6.4 North America Protein Drugs Market Size by Country
6.4.1 North America Protein Drugs Market Size by Country (2017-2022)
6.4.2 North America Protein Drugs Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Protein Drugs Market Size (2017-2028)
7.2 Europe Protein Drugs Market Size by Type
7.2.1 Europe Protein Drugs Market Size by Type (2017-2022)
7.2.2 Europe Protein Drugs Market Size by Type (2023-2028)
7.2.3 Europe Protein Drugs Market Share by Type (2017-2028)
7.3 Europe Protein Drugs Market Size by Application
7.3.1 Europe Protein Drugs Market Size by Application (2017-2022)
7.3.2 Europe Protein Drugs Market Size by Application (2023-2028)
7.3.3 Europe Protein Drugs Market Share by Application (2017-2028)
7.4 Europe Protein Drugs Market Size by Country
7.4.1 Europe Protein Drugs Market Size by Country (2017-2022)
7.4.2 Europe Protein Drugs Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Protein Drugs Market Size (2017-2028)
8.2 Asia-Pacific Protein Drugs Market Size by Type
8.2.1 Asia-Pacific Protein Drugs Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Protein Drugs Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Protein Drugs Market Share by Type (2017-2028)
8.3 Asia-Pacific Protein Drugs Market Size by Application
8.3.1 Asia-Pacific Protein Drugs Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Protein Drugs Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Protein Drugs Market Share by Application (2017-2028)
8.4 Asia-Pacific Protein Drugs Market Size by Region
8.4.1 Asia-Pacific Protein Drugs Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Protein Drugs Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Protein Drugs Market Size (2017-2028)
9.2 Latin America Protein Drugs Market Size by Type
9.2.1 Latin America Protein Drugs Market Size by Type (2017-2022)
9.2.2 Latin America Protein Drugs Market Size by Type (2023-2028)
9.2.3 Latin America Protein Drugs Market Share by Type (2017-2028)
9.3 Latin America Protein Drugs Market Size by Application
9.3.1 Latin America Protein Drugs Market Size by Application (2017-2022)
9.3.2 Latin America Protein Drugs Market Size by Application (2023-2028)
9.3.3 Latin America Protein Drugs Market Share by Application (2017-2028)
9.4 Latin America Protein Drugs Market Size by Country
9.4.1 Latin America Protein Drugs Market Size by Country (2017-2022)
9.4.2 Latin America Protein Drugs Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Protein Drugs Market Size (2017-2028)
10.2 Middle East & Africa Protein Drugs Market Size by Type
10.2.1 Middle East & Africa Protein Drugs Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Protein Drugs Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Protein Drugs Market Share by Type (2017-2028)
10.3 Middle East & Africa Protein Drugs Market Size by Application
10.3.1 Middle East & Africa Protein Drugs Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Protein Drugs Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Protein Drugs Market Share by Application (2017-2028)
10.4 Middle East & Africa Protein Drugs Market Size by Country
10.4.1 Middle East & Africa Protein Drugs Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Protein Drugs Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Details
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Protein Drugs Introduction
11.1.4 Eli Lilly Revenue in Protein Drugs Business (2017-2022)
11.1.5 Eli Lilly Recent Developments
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Details
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Protein Drugs Introduction
11.2.4 Abbott Laboratories Revenue in Protein Drugs Business (2017-2022)
11.2.5 Abbott Laboratories Recent Developments
11.3 UCB Group
11.3.1 UCB Group Company Details
11.3.2 UCB Group Business Overview
11.3.3 UCB Group Protein Drugs Introduction
11.3.4 UCB Group Revenue in Protein Drugs Business (2017-2022)
11.3.5 UCB Group Recent Developments
11.4 Schering-Plough Corporation
11.4.1 Schering-Plough Corporation Company Details
11.4.2 Schering-Plough Corporation Business Overview
11.4.3 Schering-Plough Corporation Protein Drugs Introduction
11.4.4 Schering-Plough Corporation Revenue in Protein Drugs Business (2017-2022)
11.4.5 Schering-Plough Corporation Recent Developments
11.5 Genentech
11.5.1 Genentech Company Details
11.5.2 Genentech Business Overview
11.5.3 Genentech Protein Drugs Introduction
11.5.4 Genentech Revenue in Protein Drugs Business (2017-2022)
11.5.5 Genentech Recent Developments
11.6 Johnson?Johnson
11.6.1 Johnson?Johnson Company Details
11.6.2 Johnson?Johnson Business Overview
11.6.3 Johnson?Johnson Protein Drugs Introduction
11.6.4 Johnson?Johnson Revenue in Protein Drugs Business (2017-2022)
11.6.5 Johnson?Johnson Recent Developments
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Details
11.7.2 Bristol-Myers Squibb Business Overview
11.7.3 Bristol-Myers Squibb Protein Drugs Introduction
11.7.4 Bristol-Myers Squibb Revenue in Protein Drugs Business (2017-2022)
11.7.5 Bristol-Myers Squibb Recent Developments
11.8 Novo Nordisk
11.8.1 Novo Nordisk Company Details
11.8.2 Novo Nordisk Business Overview
11.8.3 Novo Nordisk Protein Drugs Introduction
11.8.4 Novo Nordisk Revenue in Protein Drugs Business (2017-2022)
11.8.5 Novo Nordisk Recent Developments
11.9 Biogen Idec
11.9.1 Biogen Idec Company Details
11.9.2 Biogen Idec Business Overview
11.9.3 Biogen Idec Protein Drugs Introduction
11.9.4 Biogen Idec Revenue in Protein Drugs Business (2017-2022)
11.9.5 Biogen Idec Recent Developments
11.10 Dendreon Corporation
11.10.1 Dendreon Corporation Company Details
11.10.2 Dendreon Corporation Business Overview
11.10.3 Dendreon Corporation Protein Drugs Introduction
11.10.4 Dendreon Corporation Revenue in Protein Drugs Business (2017-2022)
11.10.5 Dendreon Corporation Recent Developments
11.11 Amgen Inc.
11.11.1 Amgen Inc. Company Details
11.11.2 Amgen Inc. Business Overview
11.11.3 Amgen Inc. Protein Drugs Introduction
11.11.4 Amgen Inc. Revenue in Protein Drugs Business (2017-2022)
11.11.5 Amgen Inc. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Protein Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Antibody Drugs
Table 3. Key Players of Peptide Hormones
Table 4. Key Players of Blood Products
Table 5. Key Players of Enzymes
Table 6. Global Protein Drugs Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Protein Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Protein Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Protein Drugs Market Share by Region (2017-2022)
Table 10. Global Protein Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Protein Drugs Market Share by Region (2023-2028)
Table 12. Protein Drugs Market Trends
Table 13. Protein Drugs Market Drivers
Table 14. Protein Drugs Market Challenges
Table 15. Protein Drugs Market Restraints
Table 16. Global Protein Drugs Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Protein Drugs Revenue Share by Players (2017-2022)
Table 18. Global Top Protein Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Protein Drugs as of 2021)
Table 19. Ranking of Global Top Protein Drugs Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Protein Drugs Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Protein Drugs Product Solution and Service
Table 23. Date of Enter into Protein Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Protein Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Protein Drugs Revenue Market Share by Type (2017-2022)
Table 27. Global Protein Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Protein Drugs Revenue Market Share by Type (2023-2028)
Table 29. Global Protein Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Protein Drugs Revenue Share by Application (2017-2022)
Table 31. Global Protein Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Protein Drugs Revenue Share by Application (2023-2028)
Table 33. North America Protein Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America Protein Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America Protein Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America Protein Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America Protein Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America Protein Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe Protein Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe Protein Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe Protein Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe Protein Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe Protein Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe Protein Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific Protein Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific Protein Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific Protein Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific Protein Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific Protein Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific Protein Drugs Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America Protein Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America Protein Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America Protein Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America Protein Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America Protein Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America Protein Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Protein Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Protein Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Protein Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Protein Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Protein Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Protein Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 63. Eli Lilly Company Details
Table 64. Eli Lilly Business Overview
Table 65. Eli Lilly Protein Drugs Product
Table 66. Eli Lilly Revenue in Protein Drugs Business (2017-2022) & (US$ Million)
Table 67. Eli Lilly Recent Developments
Table 68. Abbott Laboratories Company Details
Table 69. Abbott Laboratories Business Overview
Table 70. Abbott Laboratories Protein Drugs Product
Table 71. Abbott Laboratories Revenue in Protein Drugs Business (2017-2022) & (US$ Million)
Table 72. Abbott Laboratories Recent Developments
Table 73. UCB Group Company Details
Table 74. UCB Group Business Overview
Table 75. UCB Group Protein Drugs Product
Table 76. UCB Group Revenue in Protein Drugs Business (2017-2022) & (US$ Million)
Table 77. UCB Group Recent Developments
Table 78. Schering-Plough Corporation Company Details
Table 79. Schering-Plough Corporation Business Overview
Table 80. Schering-Plough Corporation Protein Drugs Product
Table 81. Schering-Plough Corporation Revenue in Protein Drugs Business (2017-2022) & (US$ Million)
Table 82. Schering-Plough Corporation Recent Developments
Table 83. Genentech Company Details
Table 84. Genentech Business Overview
Table 85. Genentech Protein Drugs Product
Table 86. Genentech Revenue in Protein Drugs Business (2017-2022) & (US$ Million)
Table 87. Genentech Recent Developments
Table 88. Johnson?Johnson Company Details
Table 89. Johnson?Johnson Business Overview
Table 90. Johnson?Johnson Protein Drugs Product
Table 91. Johnson?Johnson Revenue in Protein Drugs Business (2017-2022) & (US$ Million)
Table 92. Johnson?Johnson Recent Developments
Table 93. Bristol-Myers Squibb Company Details
Table 94. Bristol-Myers Squibb Business Overview
Table 95. Bristol-Myers Squibb Protein Drugs Product
Table 96. Bristol-Myers Squibb Revenue in Protein Drugs Business (2017-2022) & (US$ Million)
Table 97. Bristol-Myers Squibb Recent Developments
Table 98. Novo Nordisk Company Details
Table 99. Novo Nordisk Business Overview
Table 100. Novo Nordisk Protein Drugs Product
Table 101. Novo Nordisk Revenue in Protein Drugs Business (2017-2022) & (US$ Million)
Table 102. Novo Nordisk Recent Developments
Table 103. Biogen Idec Company Details
Table 104. Biogen Idec Business Overview
Table 105. Biogen Idec Protein Drugs Product
Table 106. Biogen Idec Revenue in Protein Drugs Business (2017-2022) & (US$ Million)
Table 107. Biogen Idec Recent Developments
Table 108. Dendreon Corporation Company Details
Table 109. Dendreon Corporation Business Overview
Table 110. Dendreon Corporation Protein Drugs Product
Table 111. Dendreon Corporation Revenue in Protein Drugs Business (2017-2022) & (US$ Million)
Table 112. Dendreon Corporation Recent Developments
Table 113. Amgen Inc. Company Details
Table 114. Amgen Inc. Business Overview
Table 115. Amgen Inc. Protein Drugs Product
Table 116. Amgen Inc. Revenue in Protein Drugs Business (2017-2022) & (US$ Million)
Table 117. Amgen Inc. Recent Developments
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Protein Drugs Market Share by Type: 2021 VS 2028
Figure 2. Antibody Drugs Features
Figure 3. Peptide Hormones Features
Figure 4. Blood Products Features
Figure 5. Enzymes Features
Figure 6. Global Protein Drugs Market Share by Application: 2021 VS 2028
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Other Case Studies
Figure 10. Protein Drugs Report Years Considered
Figure 11. Global Protein Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Protein Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Protein Drugs Market Share by Region: 2021 VS 2028
Figure 14. Global Protein Drugs Market Share by Players in 2021
Figure 15. Global Top Protein Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Protein Drugs as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Protein Drugs Revenue in 2021
Figure 17. North America Protein Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Protein Drugs Market Size Market Share by Type (2017-2028)
Figure 19. North America Protein Drugs Market Size Market Share by Application (2017-2028)
Figure 20. North America Protein Drugs Market Size Share by Country (2017-2028)
Figure 21. United States Protein Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Protein Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Protein Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Protein Drugs Market Size Market Share by Type (2017-2028)
Figure 25. Europe Protein Drugs Market Size Market Share by Application (2017-2028)
Figure 26. Europe Protein Drugs Market Size Share by Country (2017-2028)
Figure 27. Germany Protein Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Protein Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Protein Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Protein Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Protein Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Protein Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Protein Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Protein Drugs Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Protein Drugs Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Protein Drugs Market Size Share by Region (2017-2028)
Figure 37. China Protein Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Protein Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Protein Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Protein Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Protein Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Protein Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 43. Latin America Protein Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Protein Drugs Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Protein Drugs Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Protein Drugs Market Size Share by Country (2017-2028)
Figure 47. Mexico Protein Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Protein Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Protein Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Protein Drugs Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Protein Drugs Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Protein Drugs Market Size Share by Country (2017-2028)
Figure 53. Turkey Protein Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Protein Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Protein Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Eli Lilly Revenue Growth Rate in Protein Drugs Business (2017-2022)
Figure 57. Abbott Laboratories Revenue Growth Rate in Protein Drugs Business (2017-2022)
Figure 58. UCB Group Revenue Growth Rate in Protein Drugs Business (2017-2022)
Figure 59. Schering-Plough Corporation Revenue Growth Rate in Protein Drugs Business (2017-2022)
Figure 60. Genentech Revenue Growth Rate in Protein Drugs Business (2017-2022)
Figure 61. Johnson?Johnson Revenue Growth Rate in Protein Drugs Business (2017-2022)
Figure 62. Bristol-Myers Squibb Revenue Growth Rate in Protein Drugs Business (2017-2022)
Figure 63. Novo Nordisk Revenue Growth Rate in Protein Drugs Business (2017-2022)
Figure 64. Biogen Idec Revenue Growth Rate in Protein Drugs Business (2017-2022)
Figure 65. Dendreon Corporation Revenue Growth Rate in Protein Drugs Business (2017-2022)
Figure 66. Amgen Inc. Revenue Growth Rate in Protein Drugs Business (2017-2022)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
  • Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87
    The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
  • Global Esomeprazole Magnesium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
  • Global Combination Therapy Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
  • Global Axitinib Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68
    The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
  • Global Lyme Disease Vaccine Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......
  • Global Transdermal Absorption Patch Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
  • Global Ketoprofen Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
  • Global Methyl Salicylate Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
  • Global Diclofenac Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs